- Home
- EVAX vs PSTV Comparison
EVAX vs PSTV Comparison
Compare EVAX & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- PSTV
- Stock Information
- Founded
- EVAX 2008
- PSTV 1996
- Country
- EVAX Denmark
- PSTV United States
- Employees
- EVAX N/A
- PSTV N/A
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- PSTV Medical/Dental Instruments
- Sector
- EVAX Health Care
- PSTV Health Care
- Exchange
- EVAX Nasdaq
- PSTV Nasdaq
- Market Cap
- EVAX 17.8M
- PSTV 17.0M
- IPO Year
- EVAX 2021
- PSTV N/A
- Fundamental
- Price
- EVAX $6.29
- PSTV $0.75
- Analyst Decision
- EVAX Strong Buy
- PSTV Strong Buy
- Analyst Count
- EVAX 2
- PSTV 4
- Target Price
- EVAX $11.00
- PSTV $8.00
- AVG Volume (30 Days)
- EVAX 4.4M
- PSTV 44.0M
- Earning Date
- EVAX 10-30-2025
- PSTV 11-13-2025
- Dividend Yield
- EVAX N/A
- PSTV N/A
- EPS Growth
- EVAX N/A
- PSTV N/A
- EPS
- EVAX N/A
- PSTV N/A
- Revenue
- EVAX $3,176,000.00
- PSTV $5,317,000.00
- Revenue This Year
- EVAX N/A
- PSTV $28.09
- Revenue Next Year
- EVAX $425.50
- PSTV N/A
- P/E Ratio
- EVAX N/A
- PSTV N/A
- Revenue Growth
- EVAX 1042.45
- PSTV N/A
- 52 Week Low
- EVAX $1.20
- PSTV $0.16
- 52 Week High
- EVAX $15.50
- PSTV $2.31
- Technical
- Relative Strength Index (RSI)
- EVAX 67.86
- PSTV 62.50
- Support Level
- EVAX $3.70
- PSTV $0.59
- Resistance Level
- EVAX $7.23
- PSTV $0.94
- Average True Range (ATR)
- EVAX 0.66
- PSTV 0.08
- MACD
- EVAX 0.27
- PSTV 0.03
- Stochastic Oscillator
- EVAX 70.78
- PSTV 71.96
About EVAX Evaxion Biotech
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).